Show simple item record

The case for reactive mass oral cholera vaccinations

dc.contributor.authorReyburn, R
dc.contributor.authorDeen, J L
dc.contributor.authorGrais, RF
dc.contributor.authorBhattacharya, S K
dc.contributor.authorSur, D
dc.contributor.authorLopez, A L
dc.contributor.authorJiddawi, M S
dc.contributor.authorClemens, J D
dc.contributor.authorvon Seidlein, L
dc.date.accessioned2011-05-23T19:35:26Z
dc.date.available2011-05-23T19:35:26Z
dc.date.issued2011-01-25
dc.date.submitted2011-04-29
dc.identifier.citationPLoS Negl Trop Dis 2011;5(1):e952en
dc.identifier.issn1935-2735
dc.identifier.pmid21283614
dc.identifier.doi10.1371/journal.pntd.0000952
dc.identifier.urihttp://hdl.handle.net/10144/129950
dc.description.abstractThe outbreak of cholera in Zimbabwe intensified interest in the control and prevention of cholera. While there is agreement that safe water, sanitation, and personal hygiene are ideal for the long term control of cholera, there is controversy about the role of newer approaches such as oral cholera vaccines (OCVs). In October 2009 the Strategic Advisory Group of Experts advised the World Health Organization to consider reactive vaccination campaigns in response to large cholera outbreaks. To evaluate the potential benefit of this pivotal change in WHO policy, we used existing data from cholera outbreaks to simulate the number of cholera cases preventable by reactive mass vaccination.
dc.language.isoenen
dc.relation.urlhttp://www.plosntds.org/article/info%3Adoi%2F10.1371%2Fjournal.pntd.0000952en
dc.rightsArchived with thanks to PLoS Neglected Tropical Diseases and its Open Access policy.en
dc.subject.meshAdolescenten
dc.subject.meshAdulten
dc.subject.meshAgeden
dc.subject.meshAged, 80 and overen
dc.subject.meshChilden
dc.subject.meshChild, Preschoolen
dc.subject.meshCholeraen
dc.subject.meshCholera Vaccinesen
dc.subject.meshComputer Simulationen
dc.subject.meshDisease Outbreaksen
dc.subject.meshFemaleen
dc.subject.meshHumansen
dc.subject.meshIndiaen
dc.subject.meshInfanten
dc.subject.meshInfant, Newbornen
dc.subject.meshMaleen
dc.subject.meshMass Vaccinationen
dc.subject.meshMiddle Ageden
dc.subject.meshModels, Statisticalen
dc.subject.meshTanzaniaen
dc.subject.meshYoung Adulten
dc.subject.meshZimbabween
dc.titleThe case for reactive mass oral cholera vaccinationsen
dc.typeArticleen
dc.contributor.departmentInternational Vaccine Institute (IVI), Seoul, Korea; Epicentre, Paris, France; NICED, Kolkata, India; Ministry of Health and Social Welfare, Zanzibar, Tanzania; Menzies School of Health Research, Casuarina, Australiaen
dc.identifier.journalPLoS Neglected Tropical Diseasesen
refterms.dateFOA2019-03-04T08:44:52Z
html.description.abstractThe outbreak of cholera in Zimbabwe intensified interest in the control and prevention of cholera. While there is agreement that safe water, sanitation, and personal hygiene are ideal for the long term control of cholera, there is controversy about the role of newer approaches such as oral cholera vaccines (OCVs). In October 2009 the Strategic Advisory Group of Experts advised the World Health Organization to consider reactive vaccination campaigns in response to large cholera outbreaks. To evaluate the potential benefit of this pivotal change in WHO policy, we used existing data from cholera outbreaks to simulate the number of cholera cases preventable by reactive mass vaccination.


Files in this item

Thumbnail
Name:
110125_Reyburn_The-Case-for-Re ...
Size:
1.668Mb
Format:
PDF
Description:
Main Article
Download

This item appears in the following Collection(s)

Show simple item record